| 1 |
33804005 | Nephrogenic Systemic Fibrosis as a Complication after Gadolinium-Containing Contrast Agents: A Rapid Review. | 2021 Mar 15 |
1 |
| 2 |
22607376 | Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance. | 2012 May 20 |
2 |
| 3 |
23198628 | Gadolinium-induced NSF claim resolved in favor of plaintiff. | 2012 |
1 |
| 4 |
19421113 | [Gadolinium-enhanced thoracic CTA: retrospective analysis of image quality and tolerability in 45 patients evaluated prior to the description of nephrogenic systemic fibrosis]. | 2009 Mar |
1 |
| 5 |
18342468 | Extracellular Gd-CA: differences in prevalence of NSF. | 2008 May |
1 |
| 6 |
18633995 | Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature. | 2008 |
1 |
| 7 |
18666152 | Is NSF only the tip of the "gadolinium toxicity" iceberg? | 2008 Aug |
1 |
| 8 |
19020260 | NSF-active and NSF-inert species of gadolinium: mechanistic and clinical implications. | 2008 Dec |
2 |
| 9 |
17109993 | Gadolinium deposition in nephrogenic fibrosing dermopathy. | 2007 Jan |
1 |
| 10 |
17433041 | Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature. | 2007 Jul |
4 |
| 11 |
17441914 | Update on radiological imaging of renal cell carcinoma. | 2007 May |
1 |